Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор)

Secondary progressive multiple sclerosis: number of patients and public drug supply in Russia

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор) ◽

10.17116/medtech20214302138 ◽

2021 ◽

Vol 43 (2) ◽

pp. 38

Author(s):

V.I. Ignatyeva ◽

E.V. Derkach

Keyword(s):

Multiple Sclerosis ◽

Progressive Multiple Sclerosis ◽

Secondary Progressive Multiple Sclerosis ◽

Drug Supply ◽

Secondary Progressive ◽

Number Of Patients ◽

Public Drug

Download Full-text

Health Technology Assessment: News

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор) ◽

10.17116/medtech2021430216 ◽

2021 ◽

Vol 43 (2) ◽

pp. 6

Author(s):

Keyword(s):

Health Technology Assessment ◽

Technology Assessment ◽

Health Technology

Download Full-text

Main changes in the model of diagnosis-related groups in 2021

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор) ◽

10.17116/medtech2021430219 ◽

2021 ◽

Vol 43 (2) ◽

pp. 9

Author(s):

V.V. Omelyanovskiy ◽

M.V. Avxentyeva ◽

I.A. Zheleznyakova ◽

M.L. Lazareva ◽

D.V. Fedyaev ◽

...

Keyword(s):

Diagnosis Related Groups

Download Full-text

Optimization of payment for therapy with genetically engineered biological drugs and selective immunosuppressants at the expense of compulsory medical insurance fund in a day hospital at the regional level

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор) ◽

10.17116/medtech20214303153 ◽

2021 ◽

pp. 53

Author(s):

M.V. Sura ◽

T.V. Boyarskaya ◽

E.V. Derkach

Keyword(s):

Medical Insurance ◽

Genetically Engineered ◽

Regional Level ◽

Insurance Fund ◽

Day Hospital ◽

Biological Drugs

Download Full-text

Nomenclature of dorsopathies in the 11th revision of the International Classification of Diseases

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор) ◽

10.17116/medtech20214303121 ◽

2021 ◽

pp. 21

Author(s):

A.V. Novikova ◽

N.G. Pravdyuk ◽

N.A. Shostak ◽

N.V. Galimova

Keyword(s):

International Classification Of Diseases ◽

International Classification ◽

Classification Of Diseases

Download Full-text

Assessing the years of life lost for implementation of health development programs

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор) ◽

10.17116/medtech20214304128 ◽

2021 ◽

pp. 28

Author(s):

V.O. Kusakina ◽

V.V. Omelyanovskiy ◽

D.N. Pustovalov

Keyword(s):

Years Of Life Lost ◽

Development Programs ◽

Health Development

Download Full-text

The costs of patients with chronic kidney disease for the compulsory health insurance system in the Russian Federation

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор) ◽

10.17116/medtech20214304152 ◽

2021 ◽

pp. 52

Author(s):

E.I. Rumyantseva ◽

M.V. Avxentyeva

Keyword(s):

Chronic Kidney Disease ◽

Health Insurance ◽

Kidney Disease ◽

Russian Federation ◽

Health Insurance System ◽

Insurance System ◽

Compulsory Health Insurance ◽

The Russian Federation

Download Full-text

Value-based healthcare: analysis of European Institute of innovation and technology health guidelines

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор) ◽

10.17116/medtech20214301128 ◽

2021 ◽

pp. 28

Author(s):

Yu.A. Zuenkova

Keyword(s):

European Institute ◽

Innovation And Technology

Download Full-text

Pharmacoeconomic analysis of taliglucerase alfa used in the Russian Federation for Gaucher’s disease

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор) ◽

10.17116/medtech20214301154 ◽

2021 ◽

pp. 54

Author(s):

I.N. Dyakov ◽

S.K. Zyryanov

Keyword(s):

Russian Federation ◽

Pharmacoeconomic Analysis ◽

Gaucher's Disease ◽

Gaucher’S Disease ◽

The Russian Federation

Download Full-text

Artificial Intelligence in Healthcare: Real World Data and Patient Voice — Are We Ready for New Realities?

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор) ◽

10.17116/medtech20214302122 ◽

2021 ◽

Vol 43 (2) ◽

pp. 22

Author(s):

T.A. Goldina ◽

V.A. Burmistrov ◽

I.V. Efimenko ◽

V.F. Khoroshevskiy

Keyword(s):

Artificial Intelligence ◽

Real World ◽

Real World Data ◽

World Data ◽

Patient Voice

Download Full-text

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор)
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Fund Gelios

Secondary progressive multiple sclerosis: number of patients and public drug supply in Russia

Health Technology Assessment: News

Main changes in the model of diagnosis-related groups in 2021

Optimization of payment for therapy with genetically engineered biological drugs and selective immunosuppressants at the expense of compulsory medical insurance fund in a day hospital at the regional level

Nomenclature of dorsopathies in the 11th revision of the International Classification of Diseases

Assessing the years of life lost for implementation of health development programs

The costs of patients with chronic kidney disease for the compulsory health insurance system in the Russian Federation

Value-based healthcare: analysis of European Institute of innovation and technology health guidelines

Pharmacoeconomic analysis of taliglucerase alfa used in the Russian Federation for Gaucher’s disease

Artificial Intelligence in Healthcare: Real World Data and Patient Voice — Are We Ready for New Realities?

Export Citation Format

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор)Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Fund Gelios

Secondary progressive multiple sclerosis: number of patients and public drug supply in Russia

Health Technology Assessment: News

Main changes in the model of diagnosis-related groups in 2021

Optimization of payment for therapy with genetically engineered biological drugs and selective immunosuppressants at the expense of compulsory medical insurance fund in a day hospital at the regional level

Nomenclature of dorsopathies in the 11th revision of the International Classification of Diseases

Assessing the years of life lost for implementation of health development programs

The costs of patients with chronic kidney disease for the compulsory health insurance system in the Russian Federation

Value-based healthcare: analysis of European Institute of innovation and technology health guidelines

Pharmacoeconomic analysis of taliglucerase alfa used in the Russian Federation for Gaucher’s disease

Artificial Intelligence in Healthcare: Real World Data and Patient Voice — Are We Ready for New Realities?

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор)
Latest Publications